Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from The Cigna Group

The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish?

The Cigna Group has struggled to keep pace with the broader market over the past year, yet Wall Street remains highly optimistic on its future prospects.

Are Wall Street Analysts Predicting The Cigna Group Stock Will Climb or Sink?

Are Wall Street Analysts Predicting The Cigna Group Stock Will Climb or Sink?

The Cigna Group observed a notable drop in earnings in the recent quarter and has continued to underperform other healthcare services stocks over the past year. Yet, analysts remain strongly bullish on the stock’s prospects.

3 Healthcare Stocks for Long-Term Stability and Growth

3 Healthcare Stocks for Long-Term Stability and Growth

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Growth Stocks Wall Street Loves for 2024

Investing in growth stocks is appealing due to attractive pricing, stable business activity, easing inflation, and the Fed's gradual rate cuts, all of which create a favorable environment for capital gains. With a positive global economic outlook, it could be wise to consider investing in stocks that Wall Street loves…

3 Health Insurance Stocks to Watch as Healthcare Costs Rise

With rising medical costs and an expanding aging population, the health insurance sector is set to witness significant growth. Hence, investors looking to capitalize on this trend could consider stable health insurance stocks Elevance Health (ELV), Cigna Group (CI), and Centene (CNC). Read on….

3 Undervalued Healthcare Stocks With Strong Upside Potential

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Is The Cigna Group Stock Outperforming the Nasdaq?

The Cigna Group has outperformed the Nasdaq Composite over the past year and analysts remain bullish about the stock’s prospects.

inkl

Read news from The Economist, FT, and more,
with one subscription

3 Blue-Chip Stocks With Strong Buy Ratings

3 Blue-Chip Stocks With Strong Buy Ratings

Blue-chip stocks offer stability and consistent growth irrespective of market conditions. Thus, blue chip names Lockheed Martin (LMT), Regeneron Pharmaceuticals (REGN), and Cigna Group (CI) could be prudent additions to your portfolios. These stocks are Strong Buy-rated in our proprietary POWR Ratings system. Read on.

1 Reliable Dividend Stock to Buy at a Discount This July

1 Reliable Dividend Stock to Buy at a Discount This July

Here’s a dividend-paying gem trading at an attractive valuation, which investors can consider this July while it's still a bargain.

3 Healthcare Stocks for Defensive Investing

3 Healthcare Stocks for Defensive Investing

With the growing concern for health, rapidly surging healthcare costs, and government initiatives, the healthcare industry is positioned for robust growth. Also, investing in healthcare stocks can be a good strategy for defensive investing due to the industry's resilience to economic cycles. Thus, it could be wise to invest in…

3 High-Quality Dividend Stocks to Own This April

3 High-Quality Dividend Stocks to Own This April

Along with regular dividends, these companies all have an impressive track record of solid fundamentals and strong earnings growth forecasts.

Stock Boasts 51,455% 5-Year Dividend Growth—Is Now The Time To Buy?

Stock Boasts 51,455% 5-Year Dividend Growth—Is Now The Time To Buy?

Looking for dividend growth? We look at 3 stocks with exceptional 5-year growth. But, do they have a place in your portfolio?

Organisations

US Federal Reserve

Medicare Advantage

Medical Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

339,578 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play